A5039678718- Retinal Development and Disorders
- Photoreceptor and optogenetics research
- Retinal Diseases and Treatments
- bioluminescence and chemiluminescence research
- Glaucoma and retinal disorders
- Retinal and Optic Conditions
- Neuroinflammation and Neurodegeneration Mechanisms
- Adenosine and Purinergic Signaling
- Olfactory and Sensory Function Studies
- Fatty Acid Research and Health
- Cancer Research and Treatments
- Cholesterol and Lipid Metabolism
- S100 Proteins and Annexins
- Histone Deacetylase Inhibitors Research
- Glioma Diagnosis and Treatment
- Ocular Diseases and Behçet’s Syndrome
- Cardiovascular, Neuropeptides, and Oxidative Stress Research
- Neuropeptides and Animal Physiology
- Ocular and Laser Science Research
- Systemic Lupus Erythematosus Research
- Eicosanoids and Hypertension Pharmacology
- Nitric Oxide and Endothelin Effects
- Retinal and Macular Surgery
- Antioxidant Activity and Oxidative Stress
- Neural dynamics and brain function
Stennis Space Center
2018
University of California, Los Angeles
2015-2017
Louisiana State University Health Sciences Center New Orleans
2006-2013
Louisiana State University
2009
Abstract Amacrine cells are a heterogeneous group of interneurons that form microcircuits with bipolar, amacrine and ganglion to process visual information in the inner retina. This study has characterized morphology, neurochemistry major cell types VIP‐ires‐Cre population. VIP‐tdTomato ‐Confetti (Brainbow2.1) mouse lines were generated by crossing line either Cre‐dependent tdTomato or Brainbow2.1 reporter line. Retinal sections whole‐mounts evaluated quantitative, immunohistochemical,...
The phospholipid mediator platelet-activating factor (PAF) activates an inflammatory response that includes arachidonic acid release and prostaglandin production in the eye, increasing vascular permeability inflammation. purpose of this study is to investigate action LAU-0901, a novel PAF receptor antagonist, on experimental uveitis.Uveitis was induced Lewis rats by lipopolysaccharide treatment. LAU-0901 then delivered systemically different concentrations at plus 4 16 hours, or vehicle...